Last reviewed · How we verify
CV9201
At a glance
| Generic name | CV9201 |
|---|---|
| Sponsor | CureVac |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CV9201 CI brief — competitive landscape report
- CV9201 updates RSS · CI watch RSS
- CureVac portfolio CI